Current position: Partner
Practice area/industry focus: Intellectual Property, Dispute Resolution & Litigation
Career highlights: Jin is an experienced practitioner in the field of disputes relating to intellectual property, especially patent infringement litigation cases as well as patent invalidation cases. One of his main fields is patent disputes among pharmaceutical companies. In 2017, Jin defended Japanese generic pharmaceutical companies in a patent litigation case before the Japanese Supreme Court relating to the doctrine of equivalents, which is the second Japanese Supreme Court case dealing with the doctrine of equivalents. Further, in 2011, Jin handled a patent infringement case regarding the sale of pioglitazone tablets by pharmaceutical companies, in which he succeeded in obtaining an important ruling on a controversial legal issue relating to indirect infringement under Japanese patent law. In 2013, Jin also successfully defended a major Japanese computer company in a patent infringement case involving international standards for exchanging authentication and authorization data between security domains.
Jin also has a wide experience in other types of disputes including a WTO related dispute case and litigation cases involving complex commercial matters. In the WTO case, which was regarding a Japanese semi-governmental railway company’s procurement of an IC card system, he advised a Japanese subsidiary of a U.S. telecommunications company and handled the case with USTR’s attorneys.
After graduating New York University School of Law in 2003, Jin worked as an associate at Dallas office of Andrews Kurth Kenyon LLP, a U.S. law firm, for two years. There, Jin was engaged in a litigation involving patent rights to lithium battery technology.
Jin’s recent work includes, among others, advising a Japanese company in a U.S. litigation case involving patent rights to quantum dot technology, advising a large Japanese generic pharmaceutical company in a patent invalidation case before the Japanese Patent Office, advising Japanese generic pharmaceutical companies regarding warning letters from other pharmaceutical companies, and advising Japanese IT companies on patent infringement cases before district courts.
Jin has been a lecturer of the Japan Intellectual Property Association (JIPA), which is a non-profit, non-governmental organization with more than 1,000 corporate members, from 2014 to present. He authored: Calculation of Patent Damages - Suggestion from Case Law and Economic Approach in the United States of America, Vol.49, No.11 Japanese National Group, A.I.P.P.I., Handling of non-patented parts and attached components in the calculation of patent damages in the United States of America, Vol. 33, No.6 Journal of the Japanese Institute of International Business Law, Free Riding and Development of U.S. Trademark case law regarding Pop-Up Ads and Banner Ads, Vol.50, No.8 Japanese National Group, A.I.P.P.I.
Jin graduated from University of Tokyo, faculty of law (LL.B.) in 1993 and New York University School of Law (LL.M.) in 2003. He is admitted to practice in Japan and the New York State.
Asialaw Leading Lawyer 2018 in Intellectual Property